Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Nov;98(3):827–832. doi: 10.1111/j.1476-5381.1989.tb14611.x

An electrophysiological comparison of a novel class Ic antiarrhythmic agent, NIK-244 (ethacizin) and flecainide in canine ventricular muscle.

H Satoh 1, M Ishii 1, K Hashimoto 1
PMCID: PMC1854774  PMID: 2511994

Abstract

1. Electrophysiological effects of NIK-244 (ethacizin), a novel class I antiarrhythmic drug, were compared with flecainide in canine ventricular muscle by use of conventional microelectrode techniques. 2. At concentrations of 10(-6) M or higher, NIK-244 depressed the maximum rate of rise of depolarization (Vmax) significantly in a concentration-dependent manner. Also, the resting potential was depolarized at 10(-5) M. NIK-244 did not have any effect on the other action potential parameters or on the effective refractory period. 3. Flecainide significantly decreased Vmax at 3 x 10(-6) M or higher and the resting potential was depolarized at 10(-5) M. Like NIK-244, flecainide did not affect other action potential parameters. 4. NIK-244 and flecainide caused a use-dependent block of Vmax, and the rates of onset of inhibition at 3 Hz stimulation were 0.014 +/- 0.002 AP-1 at 2 x 10(-6) M NIK-244 and 0.021 +/- 0.012 AP-1 at 10(-5) M flecainide. Under the same conditions, the time constants of the recovery from use-dependent block were 27.1 +/- 13.3 s and 12.2 +/- 2.5 s for NIK-244 and flecainide, respectively. 5. These results suggest that NIK-244, like flecainide, should be classified as a slow kinetic drug and as Ic.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell T. J. Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res. 1983 Jun;17(6):344–352. doi: 10.1093/cvr/17.6.344. [DOI] [PubMed] [Google Scholar]
  2. Campbell T. J. Resting and rate-dependent depression of maximum rate of depolarisation (Vmax) in guinea pig ventricular action potentials by mexiletine, disopyramide, and encainide. J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):291–296. doi: 10.1097/00005344-198303000-00021. [DOI] [PubMed] [Google Scholar]
  3. Chazov E. I., Rosenshtraukh L. V., Shugushev K. K. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia. Am Heart J. 1984 Sep;108(3 Pt 1):483–489. doi: 10.1016/0002-8703(84)90412-5. [DOI] [PubMed] [Google Scholar]
  4. Courtney K. R. Interval-dependent effects of small antiarrhythmic drugs on excitability of guinea-pig myocardium. J Mol Cell Cardiol. 1980 Nov;12(11):1273–1286. doi: 10.1016/0022-2828(80)90071-1. [DOI] [PubMed] [Google Scholar]
  5. Courtney K. R. Why do some drugs preferentially block open sodium channels? J Mol Cell Cardiol. 1988 Jun;20(6):461–464. doi: 10.1016/s0022-2828(88)80073-7. [DOI] [PubMed] [Google Scholar]
  6. Hageman G. R., Neely B. H., Urthaler F., Rosenshtraukh L. V. Effects of the diethylamino analog of ethmozin (ethacizin) upon sympathetic and parasympathetic efferent activity to the canine heart. J Pharmacol Exp Ther. 1986 Jan;236(1):75–79. [PubMed] [Google Scholar]
  7. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977 Apr;69(4):497–515. doi: 10.1085/jgp.69.4.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hondeghem L. M., Katzung B. G. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta. 1977 Nov 14;472(3-4):373–398. doi: 10.1016/0304-4157(77)90003-x. [DOI] [PubMed] [Google Scholar]
  9. Nesterenko V. V., Rozenshtraukh L. V. Vliianie diétilaminovogo analoga étmozina na silu sokrashcheniia i potentsial deistviia miokarda morskoi svinki. Biull Eksp Biol Med. 1983 Aug;96(8):56–59. [PubMed] [Google Scholar]
  10. Rosenshtraukh L. V., Shugushev K. K., Smetnev A. S. Ethacizin: a new efficacious Soviet antiarrhythmic drug of the phenothiazine group. Am Heart J. 1986 Nov;112(5):932–939. doi: 10.1016/0002-8703(86)90303-0. [DOI] [PubMed] [Google Scholar]
  11. Satoh H., Hashimoto K. An electrophysiological study of amiloride on sino-atrial node cells and ventricular muscle of rabbit and dog. Naunyn Schmiedebergs Arch Pharmacol. 1986 May;333(1):83–90. doi: 10.1007/BF00569665. [DOI] [PubMed] [Google Scholar]
  12. Satoh H., Ishii M., Hashimoto K. Effect of cibenzoline, a class I antiarrhythmic drug, on action potential in canine ventricular muscle. Jpn J Pharmacol. 1987 Jun;44(2):113–119. doi: 10.1254/jjp.44.113. [DOI] [PubMed] [Google Scholar]
  13. Smetnev A. S., Shugushev Kh Kh, Rozenshtraukh L. V., Shevchenko N. M. Vliianie novogo antiaritmicheskogo preparata étatsizina (dietilaminovogo analoga étmozina) na funktsional'noe sostoianie provodiashchei sistemy serdtsa u bol'nykh s razlichnymi formami narusheniia ritma serdtsa. Ter Arkh. 1983;55(1):92–95. [PubMed] [Google Scholar]
  14. Urthaler F., Rosenshtraukh L. V., Hageman G. R., Anjukhovsky E. P., James T. N. Differential modulation of autonomic activity by ethmozin and ethacizin (analog of ethmozin) on the canine sinus node and atrioventricular junction. J Am Coll Cardiol. 1986 Jul;8(1 Suppl A):86A–94A. doi: 10.1016/s0735-1097(86)80034-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES